Acne Vulgaris — Knowledge Evaluation and Assessment of the Effectiveness of an Education Intervention on Acne
Citation(s)
Callender VD Acne in ethnic skin: special considerations for therapy. Dermatol Ther. 2004;17(2):184-95. Review.
Cheng CE, Irwin B, Mauriello D, Liang L, Pappert A, Kimball AB Self-reported acne severity, treatment, and belief patterns across multiple racial and ethnic groups in adolescent students. Pediatr Dermatol. 2010 Sep-Oct;27(5):446-52. doi: 10.1111/j.1525-1470.2010.01286.x. Epub 2010 Aug 26.
Dréno B Assessing quality of life in patients with acne vulgaris: implications for treatment. Am J Clin Dermatol. 2006;7(2):99-106. Review.
Tan JK, Vasey K, Fung KY Beliefs and perceptions of patients with acne. J Am Acad Dermatol. 2001 Mar;44(3):439-45.
Williams HC, Dellavalle RP, Garner S Acne vulgaris. Lancet. 2012 Jan 28;379(9813):361-72. doi: 10.1016/S0140-6736(11)60321-8. Epub 2011 Aug 29. Review. Erratum in: Lancet. 2012 Jan 28;379(9813):314.
Knowledge Evaluation and Assessment of the Effectiveness of an Education Intervention on Acne
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
